 Connection
Kelly Doran to Anti-Bacterial Agents
This is a "connection" page, showing publications Kelly Doran has written about Anti-Bacterial Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.366 |
|
|
|
-
Cavaco CK, Patras KA, Zlamal JE, Thoman ML, Morgan EL, Sanderson SD, Doran KS. A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing. Antimicrob Agents Chemother. 2013 Nov; 57(11):5492-9.
Score: 0.212
-
Lin AE, Autran CA, Szyszka A, Escajadillo T, Huang M, Godula K, Prudden AR, Boons GJ, Lewis AL, Doran KS, Nizet V, Bode L. Human milk oligosaccharides inhibit growth of group B Streptococcus. J Biol Chem. 2017 07 07; 292(27):11243-11249.
Score: 0.068
-
Becker SC, Roach DR, Chauhan VS, Shen Y, Foster-Frey J, Powell AM, Bauchan G, Lease RA, Mohammadi H, Harty WJ, Simmons C, Schmelcher M, Camp M, Dong S, Baker JR, Sheen TR, Doran KS, Pritchard DG, Almeida RA, Nelson DC, Marriott I, Lee JC, Donovan DM. Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus. Sci Rep. 2016 04 28; 6:25063.
Score: 0.064
-
de Figueiredo Sanches G, Lannes-Costa PS, Cristofor?to MC, Doran KS, Mattos-Guaraldi AL, Nagao PE. Streptococcus agalactiae strains isolated from cancer patients in Rio de Janeiro, Brazil. Braz J Microbiol. 2021 Mar; 52(1):303-310.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|